Ad is loading...
JPIVX
Price
$33.89
Change
+$0.36 (+1.07%)
Updated
Nov 21 closing price
RMEBX
Price
$59.28
Change
+$0.53 (+0.90%)
Updated
Nov 21 closing price
Ad is loading...

JPIVX vs RMEBX

Header iconJPIVX vs RMEBX Comparison
Open Charts JPIVX vs RMEBXBanner chart's image
JPMorgan U.S. Applied Data Sci Val I
Price$33.89
Change+$0.36 (+1.07%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R2E
Price$59.28
Change+$0.53 (+0.90%)
VolumeN/A
CapitalizationN/A
JPIVX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JPIVX vs. RMEBX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JPIVX is a Buy and RMEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 104B vs. JPIVX (179M). JPIVX pays higher dividends than RMEBX: JPIVX (1.65) vs RMEBX (1.54). JPIVX was incepted earlier than RMEBX: JPIVX (22 years) vs RMEBX (10 years). RMEBX is a more actively managed with annual turnover of: 25.00 vs. JPIVX (17.00). RMEBX has a lower initial minimum investment than JPIVX: RMEBX (250) vs JPIVX (1000000). JPIVX annual gain was more profitable for investors over the last year : 23.07 vs. RMEBX (21.63). RMEBX return over 5 years is better than : 46.23 vs. JPIVX (13.32).
JPIVXRMEBXJPIVX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years10 years-
Gain YTD22.21517.768125%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets179M104B0%
Annual Yield % from dividends1.651.54107%
Returns for 1 year23.0721.63107%
Returns for 3 years-8.8316.99-52%
Returns for 5 years13.3246.2329%
Returns for 10 years-0.1764.65-0%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UA8.430.11
+1.32%
Under Armour
SHG39.660.08
+0.20%
Shinhan Financial Group Co Ltd
HBIO2.16N/A
N/A
Harvard Bioscience
DSS1.02-0.02
-1.92%
DSS
CAPR17.79-1.13
-5.97%
Capricor Therapeutics